Inactive Instrument

Pfizer Inc. Share Price London S.E.

Equities

US7170811035

Pharmaceuticals

Real-time Estimate Cboe BZX 04:30:10 29/06/2024 am IST 5-day change 1st Jan Change
27.97 USD -23.47% Intraday chart for Pfizer Inc. +0.55% -1.48%
Sales 2024 * 60.47B 5,039B Sales 2025 * 62.71B 5,226B Capitalization 159B 13,213B
Net income 2024 * 7.28B 607B Net income 2025 * 10.81B 901B EV / Sales 2024 * 3.6 x
Net Debt 2024 * 59.14B 4,928B Net Debt 2025 * 54.22B 4,519B EV / Sales 2025 * 3.39 x
P/E ratio 2024 *
20.6 x
P/E ratio 2025 *
14.1 x
Employees -
Yield 2024 *
5.97%
Yield 2025 *
6.09%
Free-Float 59.05%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 62 01/93/01
Director of Finance/CFO 59 02/22/02
Chief Tech/Sci/R&D Officer - 01/19/01
Members of the board TitleAgeSince
Director/Board Member 66 01/20/01
Director/Board Member 64 23/17/23
Director/Board Member 60 27/13/27
More insiders
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Calendar
Related indices
More about the company